FTV vs SGMO · P/E 31, rev $6.23B vs rev $57.8M
Fortive Corp (FTV) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
FTV currently screens at market cap $24.34B and trailing P/E 31.4. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the FTV and SGMO stock pages for the full models.
Not investment advice.